Venture Life Group (VLG) Competitors GBX 57.22 -0.53 (-0.91%) As of 04:23 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock VLG vs. ANCR, DNL, EAH, STX, PXS, CHLL, MXC, RGT, CEL, and N4PShould you be buying Venture Life Group stock or one of its competitors? The main competitors of Venture Life Group include Animalcare Group (ANCR), Diurnal Group (DNL), ECO Animal Health Group (EAH), Shield Therapeutics (STX), Provexis (PXS), Chill Brands Group (CHLL), Argent BioPharma (MXC), Argent BioPharma (RGT), Celadon Pharmaceuticals (CEL), and N4 Pharma (N4P). These companies are all part of the "drug manufacturers - specialty & generic" industry. Venture Life Group vs. Its Competitors Animalcare Group Diurnal Group ECO Animal Health Group Shield Therapeutics Provexis Chill Brands Group Argent BioPharma Argent BioPharma Celadon Pharmaceuticals N4 Pharma Venture Life Group (LON:VLG) and Animalcare Group (LON:ANCR) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and media sentiment. Do institutionals & insiders have more ownership in VLG or ANCR? 69.5% of Venture Life Group shares are held by institutional investors. Comparatively, 49.0% of Animalcare Group shares are held by institutional investors. 10.4% of Venture Life Group shares are held by insiders. Comparatively, 29.5% of Animalcare Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has more volatility and risk, VLG or ANCR? Venture Life Group has a beta of 0.3, suggesting that its stock price is 70% less volatile than the S&P 500. Comparatively, Animalcare Group has a beta of 0.55, suggesting that its stock price is 45% less volatile than the S&P 500. Which has stronger valuation and earnings, VLG or ANCR? Animalcare Group has higher revenue and earnings than Venture Life Group. Animalcare Group is trading at a lower price-to-earnings ratio than Venture Life Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVenture Life Group£51.77M1.41£747.21K£0.5997.11Animalcare Group£84.90M2.28£36.55M£53.645.26 Does the media refer more to VLG or ANCR? In the previous week, Venture Life Group's average media sentiment score of 0.00 equaled Animalcare Group'saverage media sentiment score. Company Overall Sentiment Venture Life Group Neutral Animalcare Group Neutral Is VLG or ANCR more profitable? Animalcare Group has a net margin of 43.05% compared to Venture Life Group's net margin of 1.44%. Animalcare Group's return on equity of 36.62% beat Venture Life Group's return on equity.Company Net Margins Return on Equity Return on Assets Venture Life Group1.44% 0.99% 1.56% Animalcare Group 43.05%36.62%2.97% SummaryAnimalcare Group beats Venture Life Group on 9 of the 11 factors compared between the two stocks. Get Venture Life Group News Delivered to You Automatically Sign up to receive the latest news and ratings for VLG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VLG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VLG vs. The Competition Export to ExcelMetricVenture Life GroupDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£72.92M£2.16B£5.61B£3.01BDividend Yield0.09%2.92%4.23%5.02%P/E Ratio97.114.2228.52169.37Price / Sales1.41539.47426.17277,057.63Price / Cash6.4010.3536.0227.97Price / Book0.9711.438.134.60Net Income£747.21K£21.15B£3.24B£5.90B7 Day Performance-4.63%-0.53%0.20%10.76%1 Month Performance12.83%5.33%5.98%9.00%1 Year Performance16.79%1.81%26.15%57.61% Venture Life Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VLGVenture Life GroupN/AGBX 57.23-0.9%N/A+22.7%£72.92M£51.77M97.11165ANCRAnimalcare GroupN/AGBX 292.75-0.8%N/A+18.0%£200.71M£84.90M5.46220Gap DownDNLDiurnal GroupN/AN/AN/AN/A£46.33M£4.68M-3.2133EAHECO Animal Health Group3.4605 of 5 starsGBX 60.55+0.9%N/A-43.2%£41.03M£89.44M39.14234News CoverageEarnings ReportAnalyst ForecastInsider TradeGap DownSTXShield TherapeuticsN/AGBX 3+5.2%N/A+134.4%£29.58M£20.92M-0.7740,000PXSProvexisN/AGBX 0.82-5.2%N/A+32.5%£19.24M£846.98K-31.094Gap DownHigh Trading VolumeCHLLChill Brands GroupN/AN/AN/AN/A£10.89M£624.19K-215.007Earnings ReportMXCArgent BioPharmaN/AN/AN/AN/A£9.65M£1.32M-13.255Gap UpRGTArgent BioPharmaN/AN/AN/AN/A£8.31MN/A-0.65N/AGap DownHigh Trading VolumeCELCeladon PharmaceuticalsN/AGBX 13.40flatN/AN/A£8.22M£123.38K-1.682,780N4PN4 PharmaN/AGBX 0.35-6.7%N/A-30.0%£1.51M£8.84K-1.015Gap Down Related Companies and Tools Related Companies Animalcare Group Competitors Diurnal Group Competitors ECO Animal Health Group Competitors Shield Therapeutics Competitors Provexis Competitors Chill Brands Group Competitors Argent BioPharma Competitors Argent BioPharma Competitors Celadon Pharmaceuticals Competitors N4 Pharma Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:VLG) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Venture Life Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Venture Life Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.